Correction: Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling

Mol Cell Proteomics. 2020 Jan;19(1):223. doi: 10.1074/mcp.AAC119.001903.
No abstract available

Publication types

  • Published Erratum